Prior to joining Initiator Pharma he worked as a financial analyst with several Scandinavian investment banks, including ABG Sundal Collier, Handelsbanken Markets, Norden Equity and has been involved in a number of early stage biopharma companies. He holds a MSc from Norges Handelshøyskole (Norway) and a PhD from UC Berkeley.